Episode 102: Clinical Conversations: Advocacy Series - Advocating for Medicaid Coverage of AOMs

September 26, 2024 00:22:34
Episode 102: Clinical Conversations: Advocacy Series - Advocating for Medicaid Coverage of AOMs
Obesity: A Disease
Episode 102: Clinical Conversations: Advocacy Series - Advocating for Medicaid Coverage of AOMs

Sep 26 2024 | 00:22:34

/

Show Notes

In episode three of our four-part Advocacy series, Dr. Nicholas Pennings, an Obesity Medicine Specialist and Clinical Education Director at OMA, engages in a comprehensive discussion with Dr. Verlyn Warrington and Dr. Vivienne Rose on the topic of advocating for medicaid coverage of anti-obesity medications (AOMs). They will examine the current coverage landscape for AOMs, and discuss whether states have mechanisms in place to cover AOMs through Medicaid and highlight the vital role advocacy plays in shaping effective obesity treatment policies. 

Episode Guests:

Verlyn Warrington, MD

Vivienne Rose, MD

Related Resources:

Learn how you can become a champion for increased access to obesity care - https://obesitymedicine.org/about/advocacy/ 

Other Episodes

Episode 0

March 10, 2022 00:24:30
Episode Cover

Episode 54: Clinical Conversations: Improving Health and Function in the Older Patient with Obesity

In this episode, Obesity medicine specialist and OMA clinical education director Dr. Nicholas Pennings interviews Dr. John Batsis, highlighted speaker from the Overcoming Obesity...

Listen

Episode

June 28, 2024 00:28:44
Episode Cover

Episode 96: Clinical Conversations: Special Considerations for the Child with Obesity

In this episode, Executive Editor of the Obesity Medicine Association’s ‘Obesity Pillars’ online journal, Dr. Suzanne Cuda interviews Dr. Valerie O’Hara. Our experts discuss...

Listen

Episode 89

January 26, 2024 00:16:54
Episode Cover

Episode 89: Article Reviews: Prior Authorizations for Anti-Obesity Medications

In this episode, Dr. Harold Bays and Dr. Carolynn Francavilla discuss their experience with prior authorizations for obesity medications including the highly effective GLP-1...

Listen